Lisofylline inhibitor of phosphatidic acid: Phase III trial

Cell Therapeutics Inc., Seattle, Wash. Product: Lisofylline inhibitor of phosphatidic acid Indication: Advanced cancers of the blood and lymph Status: Cell Therapeutics began a double-blind, placebo-c...